
Peptilex – The Peptide Encyclopedia
- 34 peptides – from semaglutide to BPC-157 – in one book
- An evidence grade (A–E) and the key studies for every peptide
- Where each one stands in 2026 – US, EU and Switzerland
Brain & mood
62 patients with generalized anxiety disorder or neurasthenia; anxiety reduction comparable to a benzodiazepine, with fewer sedative effects.
Zozulya AA et al. – Zhurnal Nevrologii i Psikhiatrii, 2008Review of Selank's molecular actions.
Vyunova TV et al. – Protein and Peptide Letters, 2018All key studies, risks and open questions are in the book.
Source: PubMed and ClinicalTrials.gov via the Peptilex study database
Go deeper
What it is, how it acts, the key studies, risks and open questions.

ClinicalTrials.gov · name in study title · ongoing first
No registered trial yet on ClinicalTrials.gov.
PubMed · newest first
Selank, a Peptide Analog of Tuftsin, Attenuates Aversive Signs of Morphine Withdrawal in Rats
Animal studyKonstantinopolsky MA et al. · Bulletin of Experimental Biology and MedicinePMID 36322304
Human studyDoyno CR et al. · Journal of Clinical PharmacologyPMID 34396551
The Influence of Selank on the Level of Cytokines Under the Conditions of "Social" Stress
Animal studyLeonidovna YA et al. · Current Reviews in Clinical and Experimental PharmacologyPMID 32621722
Functional Connectomic Approach to Studying Selank and Semax Effects
Human studyPanikratova YR et al. · Doklady Biological SciencesPMID 32342318
Effect of Selank on Morphological Parameters of Rat Liver in Chronic Foot-Shock Stress
Animal studyFomenko EV et al. · Bulletin of Experimental Biology and MedicinePMID 31243679
Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity
Animal studyVyunova TV et al. · Protein and Peptide LettersPMID 30255741
Animal studyKasian A et al. · Behavioural NeurologyPMID 28280289
Animal studyVasil'eva EV et al. · Eksperimental'naia I Klinicheskaia FarmakologiiaPMID 29787664